Inventor

BARRETT STEPHEN DOUGLAS

US34 patents

⚠️ This page may combine multiple inventors who share the name “BARRETT STEPHEN DOUGLAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BARRETT STEPHEN DOUGLAS

WARNER LAMBERT CO

Benzenesulfonamide derivatives and their use as MEK inhibitors

2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors

1-heterocycle substituted diarylamines

Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids

4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors

Benzenesulfonamide derivatives and their use as MEK inhibitors

4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors

2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives

2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives

Method of treating or preventing septic shock by administering a MEK inhibitor

N-(4-substituted phenyl)-anthranilic acid hydroxamate esters

Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids

N-methyl-substituted benzamidazoles

Method for treating chronic pain using MEK inhibitors

N-(4 substituted phenyl)-anthranilic acid hydroxamate esters

Androgen modulators

Androgen modulators

CAYMAN CHEMICAL CO INC

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

Difluorolactam compositions for EP4-mediated osteo related diseases and conditions

Difluorolactam compositions for EP4-mediated osteo related diseases and conditions

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

Methods of synthesizing a difluorolactam analog

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

Methods of synthesizing a difluorolactam analog

Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases

Methods, systems, and compositions for promoting bone growth

Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions

PFIZER

N-(4-substituted phenyl)-anthranilic acid hydroxamate esters

Estrogen modulators

ENDRES GREGORY W

Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases

BARRETT STEPHEN DOUGLAS

Fluorescent molecular probes for use in assays that measure test compound competitive binding with SAM-utilizing proteins